ORMP
Price
$2.15
Change
-$0.07 (-3.15%)
Updated
Feb 21 closing price
Capitalization
86.67M
3 days until earnings call
TARA
Price
$3.72
Change
-$0.23 (-5.82%)
Updated
Feb 21 closing price
Capitalization
129.3M
10 days until earnings call
Ad is loading...

ORMP vs TARA

Header iconORMP vs TARA Comparison
Open Charts ORMP vs TARABanner chart's image
Oramed Pharmaceuticals
Price$2.15
Change-$0.07 (-3.15%)
Volume$191.33K
Capitalization86.67M
Protara Therapeutics
Price$3.72
Change-$0.23 (-5.82%)
Volume$270.37K
Capitalization129.3M
ORMP vs TARA Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TARA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TARA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ORMP: $2.15 vs. TARA: $3.72)
Brand notoriety: ORMP and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 59% vs. TARA: 70%
Market capitalization -- ORMP: $86.67M vs. TARA: $129.3M
ORMP [@Biotechnology] is valued at $86.67M. TARA’s [@Biotechnology] market capitalization is $129.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 1 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • ORMP’s TA Score: 1 bullish, 8 bearish.
  • TARA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, TARA is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -10.42% price change this week, while TARA (@Biotechnology) price change was -10.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ORMP is expected to report earnings on May 28, 2025.

TARA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($129M) has a higher market cap than ORMP($86.7M). ORMP YTD gains are higher at: -11.157 vs. TARA (-29.545). ORMP has higher annual earnings (EBITDA): 9.44M vs. TARA (-45.53M). ORMP has more cash in the bank: 142M vs. TARA (81.5M). ORMP has less debt than TARA: ORMP (429K) vs TARA (4.74M). ORMP (0) and TARA (0) have equivalent revenues.
ORMPTARAORMP / TARA
Capitalization86.7M129M67%
EBITDA9.44M-45.53M-21%
Gain YTD-11.157-29.54538%
P/E Ratio19.55N/A-
Revenue00-
Total Cash142M81.5M174%
Total Debt429K4.74M9%
FUNDAMENTALS RATINGS
ORMP vs TARA: Fundamental Ratings
ORMP
TARA
OUTLOOK RATING
1..100
9478
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8497
PRICE GROWTH RATING
1..100
7941
P/E GROWTH RATING
1..100
57100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (29) in the null industry is somewhat better than the same rating for ORMP (66) in the Pharmaceuticals Other industry. This means that TARA’s stock grew somewhat faster than ORMP’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as TARA (97) in the null industry. This means that ORMP’s stock grew similarly to TARA’s over the last 12 months.

TARA's Price Growth Rating (41) in the null industry is somewhat better than the same rating for ORMP (79) in the Pharmaceuticals Other industry. This means that TARA’s stock grew somewhat faster than ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (57) in the Pharmaceuticals Other industry is somewhat better than the same rating for TARA (100) in the null industry. This means that ORMP’s stock grew somewhat faster than TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTARA
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHKR0.510.01
+2.00%
Chesapeake Granite Wash Trust
RHHVF328.744.74
+1.46%
Roche Holding Ltd
ARGGY1.450.02
+1.40%
Aston Martin Lagonda Global Holdings plc.
SMNNY13.37-0.07
-0.52%
Shimano Inc.
AMADY72.28-1.33
-1.81%
Amadeus IT Group SA

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with ORMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-5.82%
ORMP - TARA
38%
Loosely correlated
-3.15%
BRNS - TARA
34%
Loosely correlated
-5.21%
MDGL - TARA
31%
Poorly correlated
-4.22%
SQZB - TARA
30%
Poorly correlated
N/A
CDTX - TARA
29%
Poorly correlated
-3.75%
More